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Abstract
Background: Neural inhibition plays an important role in auditory processing and attentional gating. Extrasynaptic GABAA
receptors (GABAAR), containing a4and d GABAAR subunits, are thought to be activated by GABA spillover outside of the
synapse following release resulting in a tonic inhibitory Cl
2 current which could account for up to 90% of total inhibition in
visual and somatosensory thalamus. However, the presence of this unique type of inhibition has not been identified in
auditory thalamus.
Methodology/Principal Findings: The present study used gaboxadol, a partially selective potent agonist for d-subunit
containing GABAA receptor constructs to elucidate the presence of extrasynaptic GABAARs using both a quantitative
receptor binding assay and patch-clamp electrophysiology in thalamic brain slices. Intense [
3H]gaboxadol binding was
found to be localized to the MGB while whole cell recordings from MGB neurons in the presence of gaboxadol
demonstrated the expression of d-subunit containing GABAARs capable of mediating a tonic inhibitory Cl
2 current.
Conclusions/Significance: Potent tonic inhibitory GABAAR responses mediated by extrasynaptic receptors may be
important in understanding how acoustic information is processed by auditory thalamic neurons as it ascends to auditory
cortex. In addition to affecting cellular behavior and possibly neurotransmission, functional extrasynaptic d-subunit
containing GABAARs may represent a novel pharmacological target for the treatment of auditory pathologies including
temporal processing disorders or tinnitus.
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Introduction
The medial geniculate body (MGB) is the thalamic nucleus of the
central auditory system serving to shape and/or gate information as
it is passed on to auditory cortical neurons. Like other sensory
thalamic structures, the MGB is considered more than a simple
relay nucleus as evidenced by recent data showing important roles
for MGB neurons in coding stimulus specific adaptation and
processing temporally complex stimuli [1,2,3]. The primary
divisions of the rat MGB are the dorsal (MGd), medial (MGm)
and ventral (MGv) [4,5,6]. The extralemniscal MGd and MGm
have diverse afferents from the inferior colliculus (IC), auditory
cortex (AC) and spinothalamic tract and efferents to the striatum,
amygdala and areas of AC [7,8]. The lemniscal MGv receives
glutamatergic input from the IC and projects to the auditory cortex
[7,8]. In the rat MGB, the two major sources of inhibition are the
GABAergic projections from IC and the thalamic reticular nucleus
(TRN) as GABAergic interneurons compose ,1% of the cellular
population [7,9,10,11,12,13]. As a result, TRN and IC inhibitory
inputs likely shape MGB response properties through tonotopically
or focused projections onto MGB neurons [1,10,14,15,16].
The GABAA receptor (GABAAR) is a heteromeric member of
the cys-loop superfamily. It forms a Cl
2 permeable ion channel
pore and serves as the primary inhibitory neurotransmitter
receptor in the brain. Nineteen GABAAR subunits (a1–6, b1–3,
c1–3, d, e, h, p and r1–3) are known, specific combinations of which
form functional GABAARs. Extensively reviewed by others,
GABAARs lacking the c subunit and containing the d-subunit
(d-GABAARs) are benzodiazepine insensitive, located extrasynap-
tically, show high ligand affinity, exhibit relatively slow desensi-
tization and mediate a tonic inhibitory Cl
2 current [17,18].
Functional d-GABAARs that mediate tonic inhibition and alter
neuronal excitability are expressed in visual and somatosensory
thalamocortical neurons, the dorsal lateral geniculate nucleus and
ventrobasal complex, respectively [19,20,21,22], but have not
been reported in the MGB.
In thalamic nuclei, the incorporation of both the a4 and d
subunits within the same GABAAR construct appears required for
tonic current activation and existing data indicate that these
subunits preferentially co-assemble [20,23,24]. Survey studies
reveal the presence of a4d subunit mRNA in the MGB, suggesting
that functional a4d-GABAAR constructs could be present in rat
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16508auditory thalamus [25]. Collectively, these data underpin the
rationale for the present set of experiments to identify the presence
of functional a4d-GABAARs and tonic inhibition in the MGB.
The present study used gaboxadol (formerly THIP), a d-subunit
specific agonist, which, when present at low (mM) concentrations,
preferentially binds and activates non-c2, d-subunit containing
GABAARs [17,26] to both label and dose-dependently activate
these receptor subtypes in auditory thalamocortical neurons.
Materials and Methods
All experiments were completed using Fischer Brown Norway
(FBN) male rats maintained on an ad libitum diet and reversed
light-dark cycle. Procedures were in accordance to protocols
approved by the Laboratory Animal Care and Use Committee of
Southern Illinois University-School of Medicine (SIU Animal
Protocol Numbers: 41-06-024 and 41-01-002).
Quantitative Receptor Binding Autoradiography
FBN rats (11-months-old) were decapitated and brains were
rapidly removed, rinsed in ice-cold phosphate buffer at 4uC
(pH 7.4), frozen in powdered dry ice and stored at 280uC. Serial
transverse sections were cut at 16 mm using a Leica CM1850
cryostat at 218uC. Selected sections were thaw-mounted onto
Superfrost/Plus slides and stored at 220uC. Anatomical locations
of the MGB were verified to match neural structures with those
previously described [4].
[
3H]Gaboxadol (Merck & Co. Inc., Rahway, NJ) was used with
modified protocols from Milbrandt and Caspary [27] and Bjarke
Ebert (personal communication). In brief, tissue sections were
subjected to pre-wash twice for 5 minutes in buffers, followed by
incubating with [
3H]gaboxadol: 10–400 nM and post-wash with
buffers for 4 quick dips. Buffer solutions used were 50 mM Tris-
citrate (pH 7.1). Non-specific binding was determined in adjacent
sections by the addition of cold excessive GABA to the ligand
buffer.
Dried slides were apposed to [
3H]-hypersensitive phosphor
screens for 3–5 days at room temperature. The phosphor screens
were scanned using a Cyclone storage phosphor system. The
MGB was outlined and analyzed using OptiQuant image analysis
software which provided tools for gray-scale quantification in
digital light units (DLU). DLUs were then converted to nCi/mg
protein using a standard curve generated from co-exposed
3H-
embedded plastic standards (ARC, St. Louis, MO) [28].
Voltage Clamp Whole Cell Recordings
22-30-day-old and 6-7-month-old FBN rats were anesthetized
with 2.5–3.0% Isolfurane gas and decapitated. Brains were rapidly
removed and placed in ice-cold solution containing (in mM): 250
sucrose, 2.5 KCl, 26 NaHCO3, 1.26 NaH2PO4, 5 MgCl2, 0.5
CaCl2, 10 glucose. To increase cell survivability, slices from six
month old animals were collected in an identical sucrose based
solution which also contained 2 mM kynurenic acid. Horizontal
slices, 200–300 mm thick containing the ventral division of MGB
were prepared using a Vibratrome 1000 Plus (Leica Microsystems
GmbH, Wetzlar, Germany) and transferred to a storage chamber
where slices were perfused for 30 minutes at 30uC with artificial
cerebrospinal fluid (ACSF) containing (in mM): 125 NaCl, 3 KCl,
1.26 NaH2PO4, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 10 glucose. Slices
were then transferred to the recording chamber one at a time as
needed. All recordings were conducted at room temperature.
Voltage-clamp recordings were conducted using a MultiClamp-
700B amplifier and digitized by a Digidata 1440A (Molecular
Devices, Sunnyvale, CA) at 5–10 kHz and filtered at 2–2.2 kHz.
Data were analyzed offline with Clampfit 10.2. Gaboxadol
(THIP), gabazine (SR-95531) and kynurenic acid were obtained
from Sigma Aldrich (St. Louis, MO). Tetrodotoxin (TTX) was
purchased from Tocris Biosciences (Ellisville, MO).
Patch-clamp recording pipettes were pulled from single-filament
borosilicate glass (O.D. 1.5 mm, I.D. 0.86 mm) using a Sutter
P-87 micropipette puller and were filled with an intracellular
solution containing (in mM): 130 CsCH3SO3, 10 HEPES, 6 NaCl,
2 MgCl, 2 MgATP and 0.3 NaGTP with a pH of 7.33 adjusted
with CsOH. The recording pipette tip resistance was 3–7 MV.
Pipettes used for focal drug application were similar to the
recording pipettes except for the tip resistance which was increased
to 6–9 MV. Once a gigaseal (.1G V seal) was obtained, the cell
membrane was ruptured resulting in whole-cell access. Patches
that exhibited a series resistance higher than 30 MV were
improved by application of additional negative pressure or
discarded. Voltage-clamp recordings were conducted at a holding
voltage of 210 mV.
All experiments were conducted in ACSF containing 2–3 mM
kynurenic acid to block ionotropic glutamate receptors. Gabox-
adol was applied to the ACSF and gabazine, a selective GABAAR
antagonist, was pressure-applied focally via a picospritzer pipette
(1–3 psi) positioned 20–30 mm from the recorded cell. TTX
(0.15 mM) was applied to ACSFto block voltage-gated Na
+
channels in experiments using 22-30-day-old animals only.
Results
Receptor binding assay indicates high levels of
[
3H]gaboxadol binding in the MGB
[
3H]gaboxadol displayed high levels of binding at low ligand
concentrations in the rat MGB (n=4) (Figure 1). Saturation
Figure 1. Receptor Binding Assay Indicating High Levels of d-containing GABAARs on MGB Neurons: Representative autoradiographs of
[
3H] gaboxadol binding in young adult rats. Warm colors (red) indicate higher levels of binding while cooler colors (blue) represent lower levels
(referenced to Relative Optical Density spectrum at left). At all three concentrations shown here (75 nM, 125 nM and 250 nM), [
3H]gaboxadol binds
selectively to GABAARs in MGB with little binding in brain regions shown in this coronal section, except for hippocampus and upper layers of
neocortex. The MGB and hippocampus are indicated by arrows labeled ‘‘MGB’’ and ‘‘HP’’, respectively with primary auditory cortex labeled as ‘‘A1’’.
doi:10.1371/journal.pone.0016508.g001
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194.64636.92 nM in the MGB (mean 6 SEM). Figure 1 shows
representative coronal sections through the MGB, displaying lower
levelsof[
3H]gaboxadolbindinginhippocampus.Itislikelythatother
sensory thalamic areas, cortex, cerebellum, etc. known to express d-
GABAAR s would show similar levels of binding, but are not present
in Figure 1 [29]. Regionally specific high levels of [
3H]gaboxadol
binding was seen in the MGB. This was in contrast to the relative
absence of binding in neighboring structures, but consistent reports
providing evidence for a4d-GABAARs in the hippocampus [30,31].
[
3H]gaboxadol binding in both MGB and hippocampus contrasts
with the relative absence of [
3H]gaboxadol binding at low ligand
concentrations in other brain regions, consistent with the low levels of
a4 and d-GABAAR subunit protein[32].
Gaboxadol activates a tonic change in whole-cell
baseline current blocked by gabazine
In vitro whole cell voltage-clamp recordings from visually
identified neurons in the MGv were conducted in control ACSF
or in ACSF containing gaboxadol (0.1, 0.3, 1, 2 or 5 mM). Under
these experimental conditions, activation of extrasynaptic GA-
BAARs caused a shift in baseline current (in voltage-clamp) or
potential (in current-clamp), suggesting the functional expression
of a4d-GABAARs in recorded neurons. For each condition, focal
application of gabazine (50 mM), a selective GABAAR antagonist,
was used to block all GABAAR-mediated currents, revealing the
presence of constitutive (control) and/or gaboxadol elicited tonic
currents. The membrane potential was clamped at 210 mV,
therefore GABAAR-mediated currents were detected as outward
shifts. Gabazine blockade caused a decrease in tonic outward
current, represented as an inward shift in baseline current
(Figure 2A). The Cl
2 equilibrium potential was estimated to be
near 260 mV. The difference between the holding current before
and during focal gabazine application (DI) was defined as the
amplitude of the tonic current in response to activation of a4d-
GABAARs. The value of DI increased as a function of gaboxadol
concentration, however even in the absence of gaboxadol, a small
tonic current was detected supporting the presence of constitutive
activation of extrasynaptic a4d-GABAARs in MGB neurons
(Figure 2B).
In an effort to address the disparity in subject age between the
two sets of experiments, MGB neurons from adult (6-7-month-old)
FBN rats were examined. In 6-month-old neurons DI for 1 mM
gaboxadol was 86.4622.8 pA (n=3; mean6SEM). Analyzed as
current density to account for any developmental morphological
changes, DI for 1 mM gaboxadol was significantly greater in 6-
month-old MGv neurons (0.9160.05 pA/pF; n=3) in compari-
son to 22-30-day-old MGv neurons (0.5060.09; n=6) (t-test;
p=0.024).
Discussion
These findings strongly support the presence of functional a4d-
GABAARs in MGB neurons. Receptor-binding autoradiorgraphy
at low ligand concentrations of the subunit selective GABAA
superagonsit gaboxadol [33] show evidence of a4d-GABAARs
expression on auditory thalamocortical cell membranes while whole
cell recordings from brain slices provide evidence for functional
likely extrasynaptic a4d-GABAARs mediating tonic inhibition.
Tonic GABAAR mediated inhibition was recorded from neurons
in 22-30-day-old and 6-7-month-old animals for consistency with
[
3H]gaboxadol binding results. These recordings suggest a
qualitative similarity between 22-30-day-old and adult MGB
neurons, but find a developmental increase in the amplitude of
the tonic current. This increase in current amplitude likely reflects
the developmental increase in d-subunit containing GABAAR
expression seen in the cerebellum and thalamus [29].
Figure 2. GABAAR Mediated Tonic Inhibition in MGB Neurons: A) Representative traces of gaboxadol-induced tonic Cl
2 currents (outward)
revealed by gabazine block, resulting in an inward shift in baseline current for MGB neurons held at 210 mV. The solid black line above the first trace
represents the continuous focal application of (50 mM) gabazine for all traces. B) Bar graph of tonic current amplitude changes revealed by focal
application of gabazine in the presence of increasing concentrations of GABAAR agonist, gaboxadol (GBX), applied to the ACSF. Current amplitudes
are represented on the y-axis with the concentration of gaboxadol on the x-axis. (*p,0.005 when compared to Control using Dunnett’s post-hoc
analysis, data underwent first-order Winsorization; n=control: 8; 0.1 mM: 4; 0.3 mM: 6; 1 mM: 6; 2 mM: 6; 5 mM: 6).
doi:10.1371/journal.pone.0016508.g002
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TRN are likely to activate tonic GABAAR currents through
feedforward or feedback inhibition (Figure 3) [1,7,9,10,11,12,13,16].
As a4d-GABAARs have been shown to regulate neuronal excitability
different from classical synaptic GABAARs in other sensory systems,
they may prove to play a significant role in processing acoustic
information. Enhanced inhibitory tone in auditory thalamic neurons
may then serve to increase signal fidelity by decreasing ‘‘jitter’’ or noise
level through hyperpolarization of the resting membrane potential
[34]. A GABA-induced persistent hyperpolarization would lower the
probability of excitatory input generated by intrinsic background noise
to cause depolarizations great enough to reach action potential
threshold. This damping/inhibition may be most important when
coding temporally complex sounds like speech under severe/noisy
listening conditions. However, work in understanding the role a4d-
GABAARs in stimulus coding in sensory thalamus is sparse.
The effect of a4d-GABAAR activation on cellular excitability
has been examined in the studies described above but under-
standing the role of this receptor subtype in terms of neurotrans-
mission per se has received less attention. For example,
hyperpolarization via a4d-GABAAR mediated tonic inhibition
has been shown to be involved in the transition from a tonic to
burst response mode in thalamic neurons through the hyperpo-
larized potential’s interaction with T-type Ca
2+ channels [22]. It
follows that this receptor subtype may participate in the generation
of thalamic oscillations. Exactly what this means in an intact
system has not been determined but dysfunctional tonic inhibition
in the MGB may be associated with tinnitus [35]. An additional
hypothesis for a functional role of a4d-GABAARs is in mediating
novelty detection through stimulus specific adaptation [1,3].
Increased ambient GABA levels from TRN inhibitory afferents
to MGB could contribute to decreased stimulus evoked firing rates
through the activation of tonic GABAAR mediated hyperpolariz-
ing currents. This type of regulation of firing rates in response to
repetitive acoustic stimuli in the MGB may be similar to what is
observed in stimulus specific adaptation in the IC and AC
[36,37,38]. Recently, the TRN, a major part of the network
responsible for generating rhythmic thalamic oscillations, was
shown to play an integral role in the detection of novel stimuli by
MGB neurons [1]. In conclusion, while the physiological role of
tonic inhibition and how exactly it influences neurotransmission is
still under investigation, candidate roles for a4d-GABAARs in the
auditory system include, but are not limited to, the regulation of
general cellular excitability, enhancement of temporal coding
fidelity and novel stimuli detection. Future studies will focus on
examining the role of a4d-GABAARs in the auditory thalamus,
providing insight into how tonic inhibition may contribute to the
extraction and/or processing of meaningful sounds. Finally, this
GABAA receptor subtype could provide a unique target for new
therapeutic agents to treat tinnitus or improve speech processing in
age-related hearing loss, two maladies thought to involve the
selective down-regulation of inhibition as a function of partial
peripheral deafferentation.
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